Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy

Neurology

Volumn 80, Issue 9, 2013, Pages 786-791

  DeGiorgio, Christopher M ^a   Soss, Jason ^a   Cook, Ian A ^a   Markovic, Daniela ^a   Gornbein, Jeffrey ^a   Murray, Diana ^a   Oviedo, Sandra ^b   Gordon, Steven ^a   Corralle Leyva, Guadalupe ^b   Kealey, Colin P ^c   Heck, Christi N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NeuroSigma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG RESISTANT EPILEPSY; EPILEPSY; EXTERNAL TRIGEMINAL NERVE STIMULATION; FEMALE; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; NERVE STIMULATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT FAILURE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; TRIGEMINAL NERVE;

ADULT; CLINICAL TRIALS, PHASE III AS TOPIC; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; TRIGEMINAL NERVE; YOUNG ADULT;

MLCS; MLOWN;

EID: 84876314397     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318285c11a     Document Type: Article

References (21)

1. Begley CE, Fabulai M, Annegers J, et al. The cost of epilepsy in the United States: an estimate from populationbased clinical and survey data. Epilepsia 2000;41:342.
2. Weibe S, Blume WT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal lobe epilepsy. New Engl J Med 2001;345:311-318.
3. Sperling MR, Feldman H, Kinman J, et al. Seizure control and mortality in epilepsy. Ann Neurol 1999;46:45-50.
4. Cockerell OC, Johnson AL, Sander JW. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994;344:918-921.
5. De Giorgio C, Murray D, Markovic D, Whitehurst T. Trigeminal nerve stimulation for epilepsy: long-term feasibility and efficacy. Neurology 2009;72:936-938.
6. Schrader LM, Cook IA, Miller PR, Maremont ER, De Giorgio CM. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav 2011;22:475-478.
7. Cook IA, DeGiorgio CM, Miller PM, Maremont ER, Schrader LM. Noninvasive neuromodulation with trigeminal nerve stimulation: a novel treatment for major depressive disorder. Poster presented at the NCDEU annual meeting, Boca Raton, June 14-17, 2010.
8. Caous CA, de Sousa Buck H, Lindsey CJ. Neuronal connections of the paratrigeminal nucleus. Auton Neurosci 2001;94:14-24.
9. Grzanna R, Chee WK, Akeyson EW. Noradrenergic projections to brainstem nuclei: evidence for differential projections from noradrenergic subgroups. J Comp Neurol 1987; 263:76-91.
10. Krout KE, Belzer RE, Loewy AD. Brainstem projections to midline and intra-laminar thalamic nuclei of the rat. J Comp Neurol 2002;448:53-101.
11. Fanselow EE, Reid A, Nicolelis AL. Reduction of pentylenetetrazole induced seizure activity in awake rats by seizuretriggered trigeminal nerve stimulation. J Neurosci 2000;20: 8160-8168.
12. De Giorgio CM, Fanselow EE, Schrader LM, Cook IA. Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am 2011;22:449-456.
13. Magdaleno-Madrigal VM, Valdes Cruz A, Vargas M, et al. Effect of electrical stimulation of the nucleus of the solitary tract on the development of electrical amygdaloid kindling in the cat. Epilepsia 2002;43:964.
14. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 1999;40:1051-1057.
15. Sasa M, Ohno Y, Nabatame H, et al. Effects of L threodops, an l-noradrenaline precursor, on locus coeruleus originating neurons in spinal trigeminal nucleus. Brain Res 1987;420:157-161.
16. Hoskin KL, Bulmer DC, Lasalandra M. Fos expression in the midbrain periaqueductal grey after trigeminal-vascular stimulation. J Anat 2001;198:29-35.
17. Weiss GK, Lewis J, Jimenez-Rivera C, Vigil A, Corcoran ME. Anti-kindling effects of locus coeruleus stimulation: mediation by ascending noradrenergic projections. Exp Neurol 1990; 108:136-140.
18. Handforth A, DeGiorgio C, Schachter S. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48-55.
19. French JA, Pedley TA. Clinical practice: initial management of epilepsy. N Engl J Med 2008;359:166-176.
20. Kramer JA. Mood disorders are linked to health related quality of life in epilepsy. Epilepsy Behav 2002;3: 491-492.
21. De Giorgio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41: 1195-2000.